These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6311113)

  • 1. [Experimental studies on the enhancing effects of the combined therapy with tegafur and cytochrome C].
    Ishibashi S
    Gan To Kagaku Ryoho; 1983 Sep; 10(9):1987-92. PubMed ID: 6311113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Regulation of enzyme activities involved in pyrimidine synthesis and its application to cancer chemotherapy].
    Shirasaka T; Fujii S
    Gan To Kagaku Ryoho; 1984 Mar; 11(3 Pt 2):760-8. PubMed ID: 6424581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of coadministration of uracil or cytosine on the anti-tumor activity of clinical doses of 1-(2-tetrahydrofuryl)-5-fluorouracil and level of 5-fluorouracil in rodents.
    Fujii S; Kitano S; Ikenaka K; Shirasaka T
    Gan; 1979 Apr; 70(2):209-14. PubMed ID: 381088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Invention of a tumor-selective 5-fluorouracil derivative named S-1 by biochemical modulation of 5-fluorouracil].
    Shirasaka T; Shimamoto Y; Kato T; Fukushima M
    Gan To Kagaku Ryoho; 1998 Feb; 25(3):371-84. PubMed ID: 9492831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antitumor activity and function of S-1, a new oral tegafur-based formulation].
    Fukushima M
    Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():19-26. PubMed ID: 16897968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-Ethynyluracil (776C85): effects on the antitumor activity and pharmacokinetics of tegafur, a prodrug of 5-fluorouracil.
    Cao S; Baccanari DP; Joyner SS; Davis ST; Rustum YM; Spector T
    Cancer Res; 1995 Dec; 55(24):6227-30. PubMed ID: 8521418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of pre-operative chemotherapy using FT-207 suppositories combined with glutathione--with special reference to histopathological antitumor effect].
    Kaga F; Kitajima M; Ikeda Y; Seki M; Yagita A; Sohma S; Fukuzumi N
    Gan To Kagaku Ryoho; 1982 Mar; 9(3):489-95. PubMed ID: 6820899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Thermotherapy for cancer of the urinary bladder in combination with tegafur and picibanil--with special reference to the serum bladder and bladder cancer tissue concentrations of tegafur in a perfusion fluid].
    Murahashi I; Kanbe K; Kaneko K; Honda M; Maeda S; Takahashi E
    Gan To Kagaku Ryoho; 1984 Sep; 11(9):1781-8. PubMed ID: 6433803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of solcoseryl and combined therapy of solcoseryl and FT-207 for mice bearing meth-A tumor].
    Iwasa H; Mimura K; Ohsaki Y; Kanabe S; Hiraide H; Mizoguchi O; Tamaki K; Kurokawa T; Hatsuse K; Kadota T; Ezoe I; Tsuru S; Zinnaka Y
    Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt):254-60. PubMed ID: 6410994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination chemotherapy with cyclophosphamide and ftorafur against advanced L1210 murine leukemia.
    Grossie VB; Rosenblum MG; Loo TL
    Cancer Treat Rep; 1982 Aug; 66(8):1631-4. PubMed ID: 6809329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of microsomal cytochrome P450 and cytosolic thymidine phosphorylase in 5-fluorouracil formation from tegafur in human liver.
    Komatsu T; Yamazaki H; Shimada N; Nagayama S; Kawaguchi Y; Nakajima M; Yokoi T
    Clin Cancer Res; 2001 Mar; 7(3):675-81. PubMed ID: 11297264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. UFT and leucovorin: a review of its clinical development and therapeutic potential in the oral treatment of cancer.
    Hoff PM; Pazdur R; Benner SE; Canetta R
    Anticancer Drugs; 1998 Jul; 9(6):479-90. PubMed ID: 9877235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antitumor potency of oral tegafur against adenocarcinoma 755 in mice is markedly enhanced by oral (E)-5-(2-bromovinyl)-2'-deoxyuridine.
    Iigo M; Yamaizumi Z; Nishimura S; Hoshi A; De Clercq E
    Jpn J Cancer Res; 1987 Apr; 78(4):409-13. PubMed ID: 3108221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Concentrations of 5-fluorouracil (5-FU) in serum and tissues at venous injection of tegafur or 5-FU--clinical study on colorectal cancer].
    Kojima T; Suzumura K; Kanemitsu T; Miyashita A; Inamura Y; Owa Y; Naruse T
    Gan To Kagaku Ryoho; 1998 Mar; 25(4):547-51. PubMed ID: 9530361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of levamisole in postoperative adjuvant immunochemotherapy of stomach cancer--randomized controlled study of MMC-tegafur combination therapy with or without levamisole. 1].
    Niimoto M; Hattori T; Itoh I; Tamada R; Inokuchi K; Orita K; Furue H; Ogawa N; Toda T; Furusawa M; Koga S; Hashimoto I; Kondo T; Fujimoto S; Sugiyama Y; Abe O; Ohya M
    Gan To Kagaku Ryoho; 1982 Dec; 9(12):2133-47. PubMed ID: 6820890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacokinetics and a phase I study of tegafur-uracil enterogranules in cancer patients].
    Kamiya O; Hoshino A; Ohara K; Nagata K; Kojima T; Sugihara T; Yamada M; Suzuki M; Kimura K; Fujii S
    Gan To Kagaku Ryoho; 1983 Dec; 10(12):2565-72. PubMed ID: 6418079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A clinical investigation of the combination therapy of 1-(2-tetrahydrofuryl)-5-fluorouracil (FH) fine granules and 5-FU dry syrup].
    Nakazawa I; Goto Y; Ouchi E; Nomura N; Suzuki N; Kikuchi T
    Gan To Kagaku Ryoho; 1982 Apr; 9(4):722-5. PubMed ID: 6820906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [An approach to prolongation of survival rate in tumor bearing mice using 5-fluorouracil in combination with various kinds of herb medicine].
    Ohta T; Tawara M; Tatsuka M; Abe H; Odashima S
    Gan To Kagaku Ryoho; 1983 Aug; 10(8):1858-65. PubMed ID: 6411005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Combination therapy of continuous venous infusion (CVI) of 5-FU and low dose consecutive cisplatin (CDDP), and the new oral anti-cancer drug S-1 for advanced gastro-intestinal cancer].
    Shirasaka T; Aiba K; Araki H; Suzuki M; Terashima M; Mikami Y
    Gan To Kagaku Ryoho; 1999 Mar; 26(4):456-66. PubMed ID: 10097742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative clinical study of adjuvant postoperative chemotherapy (5-FU, Tegafur, 5-FU + MMC) in curatively resected cases of gastric cancer. Study Group on 5-FU Oral Adjuvant Chemotherapy in Gastric Cancer].
    Nakajima T; Miwa K; Ohmori Y; Sakabe T; Fujii M; Kajitani T
    Gan To Kagaku Ryoho; 1996 Aug; 23(9):1161-8. PubMed ID: 8751804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.